Clinical Trials for Drug: INCB054828

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-16-64 A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy Open